Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632054 · ClinicalTrials.gov registry record · NA
Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,283
- Enrollment target
NCT06632054 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,283 participants.
The verdict
NCT06632054, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,283 participants
- Enrollment target
Study Summary
The research team will compare the efficacy of targeted text message reminders against currently used phone call reminders at increasing patient completion of fecal immunochemical test (FIT) for colon cancer screening.
Interventions
- BEHAVIORAL Text Message Reminders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,283 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2025-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06632054
The ClinicalTrials.gov registry entry for NCT06632054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text Message Reminders is the first listed.
NCT06632054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06632054 about?
NCT06632054 is a clinical study titled "Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs". The research team will compare the efficacy of targeted text message reminders against currently used phone call reminders at increasing patient completion of fecal immunochemical test (FIT) for colon cancer screening.
What is the current status of trial NCT06632054?
This trial is currently completed. It is a NA study. The enrollment target is 1,283 participants. The study started on 2025-04-07. Estimated completion is 2025-07-15.
What interventions are being tested in trial NCT06632054?
The interventions under investigation include: Text Message Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT06632054?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.